Vaccination News

In this episode, Joel M. Gelfand, MD, MSCE, is joined by Leonard H. Calabrese, DO, and Amesh Adalja, MD, FIDSA, as they discuss quarantine and isolation guidelines, emerging therapies to treat COVID-19, and the anticipated future of the COVID-19 pandemic.

The proportion of women in the U.S. who were not up to date on recommended cervical cancer screening significantly increased from 2005 to 2019, according to findings published in JAMA Network Open.

Numerous studies have shown that COVID-19 poses significant health risks to pregnant women and their offspring — with increased rates of preeclampsia, preterm birth and even perinatal death, for example.

Booster doses of COVID-19 vaccine provide the best protection against the omicron variant, according to data from three new studies published Friday, including two in MMWR.

A quality improvement intervention increased vaccination adherence among patients with inflammatory bowel disease on immunosuppressive therapy, according to research presented at the Crohn’s and Colitis Congress.

Two studies published last year in Clinical Pediatrics described how COVID-19 lockdowns led to a lack of routine vaccinations for infants and young children early in the pandemic.

Last week, the CDC updated its consumer COVID-19 mask guidance to say for the first time that people can wear N95 or KN95 respirators.

The COVID-19 pandemic could reverse improvements made in recent decades toward HPV vaccination efforts, according to Mona Saraiya, MD, MPH.

A study conducted in two U.S. states between May and November last year found that both vaccination and prior infection protected people against infection and hospitalization from COVID-19, researchers reported in MMWR.

WHO recently announced that there is not enough evidence to conclude that healthy children and adolescents require a COVID-19 booster. Instead, the world health agency said that boosters should be reserved for more vulnerable populations.